Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Heyi Gong

Phase III Study of Cisplatin With Pemtrexed or Vinorelbine Plus Concurrent Late Course Accelerated Hyperfractionated Radiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

Oncotarget

Oncology

2016

English

Elective Lymph Node Irradiation Late Course Accelerated Hyper-Fractionated Radiotherapy Plus Concurrent Cisplatin-Based Chemotherapy for Esophageal Squamous Cell Carcinoma: A Phase II Study

English

Related publications

Oral Vinorelbine and Cisplatin With Concomitant Radiotherapy in Stage III Non-Small Cell Lung Cancer (NSCLC): A Feasibility Study

Oncology Research and Treatment

English

Gemcitabine Plus Vinorelbine in Elderly or Unfit Patients With Non-Small Cell Lung Cancer

British Journal of Cancer

Cancer Research

Oncology

2000

English

Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely Resected Stage IB and II Non–Small-Cell Lung Cancer: Updated Survival Analysis of JBR-10

Journal of Clinical Oncology

English

Phase I Study of Celecoxib With Concurrent Irinotecan, Cisplatin, and Radiation Therapy for Patients With Unresectable Locally Advanced Non-Small Cell Lung Cancer

Frontiers in Oncology

Cancer Research

Oncology

2011

English

Functional Dose-Volume Histograms for Predicting Radiation Pneumonitis in Locally Advanced Non-Small Cell Lung Cancer Treated With Late-Course Accelerated Hyperfractionated Radiotherapy

Experimental and Therapeutic Medicine

English

Randomized Phase III Trial of Irinotecan Plus Cisplatin Versus Etoposide Plus Cisplatin in Chemotherapy-Naïve Korean Patients With Extensive-Disease Small Cell Lung Cancer

Cancer Research and Treatment

Cancer Research

Oncology

2019

English

Which Patients With Stage III Non-Small Cell Lung Cancer Should Undergo Surgical Resection?

English

Use of Hypofractionated Radiation Therapy With Concurrent Chemotherapy in Inoperable Stage II/III Non–small Cell Lung Cancer

International Journal of Radiation Oncology Biology Physics

English

P1.17-14 Outcomes of Hypofractionated Radiation Therapy (HFRT) With Concurrent Chemotherapy in Patients With Stage III Non Small Cell Lung Cancer (NSCLC)

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Heyi Gong

Phase III Study of Cisplatin With Pemtrexed or Vinorelbine Plus Concurrent Late Course Accelerated Hyperfractionated Radiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

Elective Lymph Node Irradiation Late Course Accelerated Hyper-Fractionated Radiotherapy Plus Concurrent Cisplatin-Based Chemotherapy for Esophageal Squamous Cell Carcinoma: A Phase II Study

Related publications

Oral Vinorelbine and Cisplatin With Concomitant Radiotherapy in Stage III Non-Small Cell Lung Cancer (NSCLC): A Feasibility Study

Gemcitabine Plus Vinorelbine in Elderly or Unfit Patients With Non-Small Cell Lung Cancer

Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely Resected Stage IB and II Non–Small-Cell Lung Cancer: Updated Survival Analysis of JBR-10

Phase I Study of Celecoxib With Concurrent Irinotecan, Cisplatin, and Radiation Therapy for Patients With Unresectable Locally Advanced Non-Small Cell Lung Cancer

Functional Dose-Volume Histograms for Predicting Radiation Pneumonitis in Locally Advanced Non-Small Cell Lung Cancer Treated With Late-Course Accelerated Hyperfractionated Radiotherapy

Randomized Phase III Trial of Irinotecan Plus Cisplatin Versus Etoposide Plus Cisplatin in Chemotherapy-Naïve Korean Patients With Extensive-Disease Small Cell Lung Cancer

Which Patients With Stage III Non-Small Cell Lung Cancer Should Undergo Surgical Resection?

Use of Hypofractionated Radiation Therapy With Concurrent Chemotherapy in Inoperable Stage II/III Non–small Cell Lung Cancer

P1.17-14 Outcomes of Hypofractionated Radiation Therapy (HFRT) With Concurrent Chemotherapy in Patients With Stage III Non Small Cell Lung Cancer (NSCLC)